期刊文献+

口腔癌患者外周血树突状细胞的体外培养及表型分析 被引量:4

In vitro culture and phenotype analysis of monocyte-derived dendritic cell from peripheral blood of patients with oral carcinoma
下载PDF
导出
摘要 目的:研究口腔癌患者外周血单核细胞来源的树突状细胞(dendritic cell,DC)形态、表型,与正常人进行比较并分析其临床意义。方法:15例口腔癌患者(实验组)及正常人(对照组)外周血单核细胞经GM-CSF,IL-4及TNF-α诱导培养,获取成熟树突状细胞,光镜和电镜观察细胞形态,流式细胞仪检测细胞表型CD1a、CD83、CD80、CD86和HLA-DR的表达变化。结果:培养7d后,2组均诱导出典型形态和表型的树突状细胞,实验组CD83、CD1a的表达率较对照组低,差异有统计学意义(均P<0.001),但CD86、CD80、HLA-DR表达率2组差异无统计学意义(均P>0.05)。结论:口腔鳞癌患者外周血单核细胞来源的DC经细胞因子诱导培养,能扩增出较大量高纯度并保持功能活性的成熟DC,为进一步开展以DC为基础的生物治疗和研究打下了基础。 Objective: To compare the phenotype of induced dendritic cell (DC) derived from peripheral blood of the healthy individuals and the patients with oral carcinoma. Methods: 15 patients with oral carcinomal at stages II or above were assigned to study group and 15 cases of healthy volunteers were assigned to control group. Leukocyte were isolated by density centrifugation. Adherent fractions were incubated in present of GM-CSF, IL-4 and TNF-α for 7 days in vitro. The morphological change of the cultured cells was observed by light microscopy and electronic microscopy. The phenotype expressions of CD83, CD1 a, CD86, CD80, HLA-DR were analysized by flow eytometry. Results:Typical DCs were obtained from two groups after 7 days culture. The expression rate of CD83, CD1 a on DC from healthy volunteers was significantly higher than that from patients ( P 〈 0. 001 ). The DC from healthy volunteers had the higher expression level of CD80, CD86 and HLA-DR than that from patients, but with no statistically difference (P 〉 0. 05 ). Condusion: DC derived from oral cancer patient's peripheral blood monocyte might be more matured and is a good cell model for further inununotherapy and research.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2007年第6期789-792,共4页 Journal of Practical Stomatology
基金 河北省高校强势学科肿瘤学科经费资助(2007~2010)
关键词 口腔肿瘤 树突状细胞 细胞因子 细胞表型 Mouth neoplasms Dendritic cell Cell factor Phenotype of cell
  • 相关文献

参考文献12

  • 1Ponsaerts P, Van Tendeloo VF, Bememan ZN. Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol, 2003, 134(3) :378
  • 2Griffioen M, Borghi M, Schrier PI,et al. Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates. Cancer Immunol Immunother, 2004, 53(8): 715
  • 3Hohl L, Zelle-Rieser C, Gander H, et al. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res, 2002, 8 ( 11 ) : 3369
  • 4Ferlazzo G, Klein J, Paliard X, et al. Dendritic cells generated from CD34-progenitor cells with fit-3 ligand, C-kit lig- and, GM-CSF, IL-4 and TNF-α are functional antigen-presenting cells resembling mature monocyle- derived dendritic cells. J Immunother, 2000, 23 ( 1 ) :48
  • 5Ratta M, Curti A, Fogli M, et al. Efficient presentation of tumor idiotype toautologous T cells by CD83 + dendritic cells derived from highly purified circulating CD14 + monocytes in multiply myeloma patients. Exp Hematol, 2000, 28 (8) :931
  • 6Bender A, Sapp M, Schuler G, et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods, 1996, 196(2): 121
  • 7Thumher M, Papesh C, Ramoner R, et al. In vitro generation of CD83 + human blood dendritic cells for active tumor immunotherapy. Exp Hematol, 1997, 25 (3) :232
  • 8Dauer M, Obermaier B, Herten J, et al. Mature dendritic cells derived from human monocytes within 48 hours : a novel strategy for dendritic cell differentiation from blood precursors. J Immunol, 2003, 170(8) : 4069
  • 9Miller PW, Sharam S, Stolina M, et al. Intraumoral administration of adenoviral IL-7 gene-modified dendritic cells augments specific antitumor immunity and achives tumor eradication. Hum Geng Ther, 2000, 11(1) :53
  • 10唐朝晖,邹声泉,邱文洪,杨想平,裘法祖.胰腺癌患者外周血中树突状细胞的分离、纯化与扩增[J].中国普外基础与临床杂志,2003,10(1):20-21. 被引量:4

二级参考文献5

  • 1[4]Mule JJ. Tumor vaccine strategies that employ dendritic cells and tumor lysates: experimental and clinical studies [J]. Immunol Invest, 2000; 29(2) ∶ 127
  • 2[5]Meidenbauer N, Andreesen R, Mackensen A.Dendritic cells for sp-ecific cancer immunotherapy [J].Biol Chem, 2001; 382(4) ∶ 507
  • 3[1]Schnurr M, Galambos P, Scholz C,et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines [J].Cancer Res, 2001; 61(17) ∶ 6445
  • 4[2]Schott M, Seissler J, Feldkamp J,et al. Dendritic cell immunotherapy induces antitumour response in parathyroid carcinoma and neuroendocrine pancreas carcinoma [J].Horm Metab Res, 1999; 31(12) ∶ 662
  • 5[3]Ninomiya T, Akbar SM, Masumoto T, et al. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocelluar carcinoma [J]. J Hepatol, 1999; 31(2) ∶ 323

共引文献3

同被引文献40

  • 1陈永熙,周同,赵亚鹏,吴开胤,陈楠.DC-SIGN与免疫调节[J].生命科学,2006,18(2):111-115. 被引量:7
  • 2Rongcun Y, Salazar Onfray F, Chari J. Identification of new HER2/neu -- derived peptide epitopes that can he dieit specific CTL against autologous and allogeneic carcinomas and melanomas[J ]. J Immunol, 1999,163 (2) :1037 - 1042.
  • 3Lambert LA, Bibson GR, Maloney M, et al. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens[J]. Immunother, 2001, 24:232- 236.
  • 4Gong JL, Najmosama N, Chen DS, et al. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity[J]. Immunol, 2000,165(3) : 1705 - 1711.
  • 5Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell - dendritic cell hybrids[J]. Nat Med, 2000, 6 (21) : 332 - 336.
  • 6Hsu FJ, Benike C, Fagnoni F, et al, Vaccination of patients with B - cell lymphoma using autologous antigen - pulsed dendritic cells[J]. Nat Med, 1996, 2(1) :52 - 58.
  • 7Arthur JF, Butterfield LH, Roth MD, et al.A comparison of gene transfer methods in human dendritic cells[J]. Cancer Gene Ther, 1997,4(1) :17- 25.
  • 8Nishioka Y, Nishimura N, Suzuki Y, et al. Human monocyte-derived and CD83 + blood dendritic cells enhance NK cell- mediated cytotoxicity[ J ]. Eur - J - Immunol, 2001 ; 31 (9) : 2633 - 41.
  • 9Shimarnura H, Cumberland R, Hiroishi K, et al. Murine dendritic eeU induced tumor apoptosis is partially mediated by nitric oxide[J]. J - lmmunother, 2002, (3) :226 - 34.
  • 10Yang R, Xu D, Zhang A, et al. Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs[J]. Int- 3 - Cancer, 2001, 94(3 ) :407 - 13.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部